DHEA
Half-Life (t½) PO: 24h
Formula C19H28O2
Molecular Weight 288.42 g/mol
Aliases Dehydroepiandrosterone, Prasterone Pharmacological Mechanism Most abundant adrenal steroid in humans. Precursor to androgens (testosterone) and estrogens (estrone, estradiol) via 3β-HSD and aromatase. Also a neurosteroid — modulates GABA-A and NMDA. Levels decline ~80% from peak (age 20) to age 70 — rationale for postmenopausal supplementation, though clinical effects are modest.
Half-Life & Elimination Curve (PO: 24h) 100% 50% 25% 12.5% 0% 0h 0×t½ 24h 1×t½ 48h 2×t½ 3d 3×t½ 4d 4×t½ 5d 5×t½ 0×t½ (0h): 100% remaining (~0.315 mg/L) 1×t½ (24h): 50% remaining (~0.158 mg/L) 2×t½ (48h): 25% remaining (~78.8 µg/L) 3×t½ (3d): 12.5% remaining (~39.4 µg/L) 4×t½ (4d): 6.3% remaining (~19.7 µg/L) 5×t½ (5d): 3.1% remaining (~9.85 µg/L) Plasma (PO) t½ Decay (24h)
0×t½ 0h 100% (0.315 mg/L) 1×t½ 24h 50% (0.158 mg/L) 2×t½ 48h 25% (78.8 µg/L) 3×t½ 3d 12.5% (39.4 µg/L) 4×t½ 4d 6.3% (19.7 µg/L) 5×t½ 5d 3.1% (9.85 µg/L) Dosing Guidelines Oral (PO): Typical 33.3 mg (Range: 25–50 mg)Transdermal (TD): Typical 33.3 mg (Range: 25–50 mg)Pharmacokinetic Parameters Oral (PO): Bioavailability (F): 60% · Volume of Distribution (Vd): 56 L · Absorption (ka): 0.8 h⁻¹ (t½ka ≈ 52m) [PMID 15037408 ]Pathways It Modulates Target Organ Systems Chemical Structure & Identifiers InChIKey: FMGSKLZLMKYGDP-USOAJAOKSA-NSMILES: C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC=C4[C@@]3(CC[C@@H](C4)O)CReferences Directory Compounds Registry Human Biology Hub